Steve Li

Title: Innovator Spotlight: Steve Li

Introduction

Steve Li is a noteworthy inventor based in Hong Kong, China, recognized for his contributions to veterinary medicine. His work primarily focuses on developing effective treatments for parasite infestations in animals, showcasing his commitment to improving animal health and welfare.

Latest Patents

Li holds a patent for a novel macrocyclic lactone tablet formulation. This invention pertains to a tablet designed for administration to animals for treating parasitic infections. The formulation includes at least one macrocyclic lactone compound characterized by its anthelmintic activity, which is dissolved in an organic solvent and then formulated into a stable tablet. These tablets demonstrate a high degree of stability over time, ensuring that animals receive a therapeutically effective dose when needed.

Career Highlights

Steve Li is currently affiliated with Bayer New Zealand Limited, where he applies his expertise in pharmaceutical formulation. His dedication to innovation has led to breakthroughs in veterinary treatments, enhancing the efficacy of medications available for consumer use.

Collaborations

Throughout his career, Li has collaborated with talented professionals like Karthigeyan Nanjan and Fadil Al Alawi. These partnerships have cultivated an environment of shared knowledge and creativity, which is essential for advancing research and developing groundbreaking products in the field of veterinary medicine.

Conclusion

Steve Li's commitment to innovation in veterinary pharmaceuticals exemplifies the significant impact inventors can have on animal health. His patented macrocyclic lactone tablet formulation not only reflects his inventive spirit but also serves as a crucial advancement in treating parasitic infections effectively. As he continues to work with leading professionals at Bayer New Zealand Limited, the future of animal health looks promising with Li's contributions leading the way.